Searching News Database: GPCR
HSMN NewsFeed - 30 Mar 2020
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
HSMN NewsFeed - 1 Nov 2018
Chris Cargill Appointed Executive Vice President and Chief Financial Officer of Sosei
Chris Cargill Appointed Executive Vice President and Chief Financial Officer of Sosei
HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
HSMN NewsFeed - 1 Apr 2014
Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy
Trevena Appoints Robert Prachar as Senior Vice President, Commercial and Corporate Strategy
HSMN NewsFeed - 14 Nov 2013
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
HSMN NewsFeed - 18 Oct 2012
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
HSMN NewsFeed - 1 Feb 2011
Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application
Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application
HSMN NewsFeed - 21 Jul 2010
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
HSMN NewsFeed - 8 Dec 2009
Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb
Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb
HSMN NewsFeed - 25 Sep 2006
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
HSMN NewsFeed - 12 Sep 2006
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
Arena Pharmaceuticals Initiates Lorcaserin Phase 3 Obesity Clinical Trial
HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
Additional items found! 29
Members Archive contains
29 additional stories matching:
GPCR
(Password required)
GPCR
(Password required)